Propylthiouracil before 131I therapy of hyperthyroid diseases: Effect on cure rate evaluated by a randomized clinical trial

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4439-4444

  Bonnema, S J ^a   Bennedbaek F N ^a   Veje, A ^a   Marving, J ^a   Hegedus L ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; IODINE 131; LEVOTHYROXINE; PREDNISONE; PROPRANOLOL; PROPYLTHIOURACIL; THYROTROPIN; ANTITHYROID AGENT; RADIOACTIVE IODINE; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE 131 UPTAKE TEST; MAJOR CLINICAL STUDY; MALE; MYXEDEMA; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; RANDOMIZED CONTROLLED TRIAL; THYROID FUNCTION TEST; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TOXIC GOITER; TREATMENT OUTCOME; BLOOD; MIDDLE AGED;

ADULT; AGED; ANTITHYROID AGENTS; FEMALE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROPYLTHIOURACIL; THYROTROPIN; THYROXINE; TREATMENT OUTCOME;

EID: 4644253755     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0247     Document Type: Article

References (33)

1. Solomon B, Glinoer D, Lagasse R, Wartofsky L 1990 Current trends in the management of Graves' disease. J Clin Endocrinol Metab 70:1518-1524
2. 131I therapy. Br Med J 16:151-154
3. Clerc J, Izembart M, Dagousset F, Jais JP, Heshmati HM, Chevalier A, Leger AF, Barritault L 1993 Influence of dose selection on absorbed dose profiles in radioiodine treatment of diffuse toxic goiters in patients receiving or not receiving carbimazole. J Nucl Med 34:387-393
4. Reynolds LR, Kotchen TA 1979 Antithyroid drugs and radioactive iodine. Fifteen years' experience with Graves' disease. Arch Intern Med 139:651-653
5. Tuttle RM, Patience T, Budd S 1995 Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease. Thyroid 5:243-247
6. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T 1997 The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol (Oxf) 47:425-430
7. Imseis RE, Vanmiddlesworth L, Massie JD, Bush AJ, Vanmiddlesworth NR 1998 Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism. J Clin Endocrinol Metab 83:685-687
8. Turton DB, Silverman ED, Shakir KM 1998 Time interval between the last dose of propylthiouracil and I-131 therapy influences cure rates in hyperthyroidism caused by Graves' disease. Clin Nucl Med 23:810-814
9. Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA 2001 Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 86:3611-3617
10. Körber C, Schneider P, Korber-Hafner N, Hanscheid H, Reiners C 2001 Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre? Eur J Nucl Med 28:1360-1364
11. 131I therapy for the treatment of hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab 87:1073-1077
12. Nygaard B, Hegedüs L, Ulriksen P, Nielsen KG, Hansen JM 1999 Radioiodine therapy for multinodular toxic goiter. Arch Intern Med 159:1364-1368
13. Ahmad AM, Ahmad M, Young ET 2002 Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis. Eur J Endocrinol 146:767-775
14. Cooper DS 2003 Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab 88:3474-3481
15. Bonnema SJ, Bartalena L, Toft AD, Hegedüs L 2002 Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres. Eur J Endocrinol 147:1-11
16. Andrade VA, Gross JL, Maia AL 2001 The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study. J Clin Endocrinol Metab 86:3488-3493
17. Braga M, Walpert N, Burch HB, Solomon BL, Cooper DS 2002 The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial. Thyroid 12:135-139
18. Hegedüs L 1990 Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease (thesis). Dan Med Bull 37:249-263.
19. Pedersen-Bjergaard U, Kirkegaard C 1997 Serum TSH and the response to radioiodine treatment of toxic multinodular goitre. Eur J Endocrinol 137: 365-369
20. Pantos C, Malliopoulou V, Mourouzis I, Sfakianoudis K, Tzeis S, Doumba P, Xinaris C, Cokkinos AD, Carageorgiou H, Varonos DD, Cokkinos DV 2003 Propylthiouracil-induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischaemia-reperfusion. J Endocrinol 178: 427-435
21. Isman CA, Yegen BC, Alican I 2003 Methimazole-induced hypothyroidism in rats ameliorates oxidative injury in experimental colitis. J Endocrinol 177:471-476
22. Imamura M, Aoki N, Saito T, Ohno Y, Maruyama Y, Yamaguchi J, Yamamoto T 1986 Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils. Acta Endocrinol (Copenh) 112:210-216
23. 131iodine. J Nucl Med 43:856-861
24. Andrade VA, Gross JL, Maia AL 1999 Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism. J Clin Endocrinol Metab 84:4012-4016
25. 131I ablation for Graves' disease. J Clin Endocrinol Metab 86:3016-3021
26. McDermott MT, Kidd GS, Dodson Jr LE, Hofeldt FD 1983 Radioiodine-induced thyroid storm. Case report and literature review. Am J Med 75:353-359
27. Aro A, Huttunen JK, Lamberg BA, Pelkonen R, Ikkala E, Kuusisto A, Rissanen V, Salmi J, Tervonen S 1981 Comparison of propranolol and carbimazole as adjuncts to iodine-131 therapy of hyperthyroidism. Acta Endocrinol (Copenh) 96:321-327
28. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H 1997 Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 7:247-251
29. 131I treatment of hyperthyroidism. Thyroidology 9:55-59
30. Marcocci C, Gianchecchi D, Masini I, Golia F, Ceccarelli C, Bracci E, Fenzi GF, Pinchera A1990 A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 13:513-520
31. Nakazato N, Yoshida K, Mori K, Kiso Y, Sayama N, Tani JI, Nakagawa Y, Ito S 1999 Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease. Thyroid 9:775-779
32. Velkeniers B, Cytryn R, Vanhaelst L, Jonckheer MH 1988 Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered. Lancet 1:1127-1129
33. 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial. Eur J Endocrinol 149:485-492